Therapeutic areas

More filters

Favourite

Popular

Promote

Welcome to Servier's content hub for healthcare professionals

Trending

Cardiometabolism 16.01.2025

My Health Partner, the ideal partner to help patients understand their disease better and improve their everyday lifestyle! Learn more

My Health Partner, the ideal partner to help patients understand their disease better and improve their everyday lifestyle!

0:29

Trending

CardiometabolismOncologyVenous Disease 03.06.2025

Welcome to My Servier Middle East Portal Learn more

Welcome to My Servier Middle East Portal

0:54

Discover more articles, guidelines and events.

Show: Favourite Popular Promoted

Filters

SERVIER MIDDLE EAST ONCOLOGY

Onco Portfolio

Oncology 23.10.2026

SERVIER MIDDLE EAST ONCOLOGY

Preserving Vascular Health: The Importance of Controlling Cardiometabolic Risk Factors

This educational asset highlights the progressive impact of uncontrolled cardiometabolic risk factors, including hypertension, type 2 diabetes, and dyslipidemia, on vascular health. It illustrates how early vascular changes can evolve into atherosclerosis and increased cardiovascular risk, emphasizing the importance of timely risk factor management to prevent long-term cardiovascular complications.

Cardiometabolism 04.10.2026

Preserving Vascular Health: The Importance of Controlling Cardiometabolic Risk Factors

The Impact of Uncontrolled Cardiometabolic Diseases on Vascular Health

Cardiometabolism 28.09.2026

The Impact of Uncontrolled Cardiometabolic Diseases on Vascular Health

RACING Trial: Rethinking LDL-C Lowering in ASCVD

Explore the RACING trial and its subgroup analyses comparing moderate-intensity statin + ezetimibe combination therapy with high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.

Cardiometabolism 24.09.2026

RACING Trial: Rethinking LDL-C Lowering in ASCVD

ADD2DIA: Real-World Effectiveness of SGLT2i + Gliclazide MR

Explore long-term real-world evidence showing early and sustained glycemic control with SGLT2i + gliclazide MR, alongside improvements in cardiometabolic risk factors and favorable tolerability.

Cardiometabolism 23.09.2026

ADD2DIA: Real-World Effectiveness of SGLT2i + Gliclazide MR

Perindopril and Cough: What Do We See in Clinical Practice?

Prof. Claudio Borghi shares his clinical experience and perspective on the incidence of cough with perindopril treatment in everyday practice.

Cardiometabolism 23.09.2026

Perindopril and Cough: What Do We See in Clinical Practice?

Indapamide-Based Treatment Evidence Beyond BP Reduction

Explore the pooled analysis of four trials evaluating indapamide, mostly combined with perindopril, and its impact on mortality and cardiovascular outcomes.

Cardiometabolism 16.09.2026

Indapamide-Based Treatment Evidence Beyond BP Reduction

Reducing Cardiovascular Mortality: New Insights from the Experts

Prof. Martin Strauss and Prof. Stefano Masi discuss new insights into cardiovascular mortality reduction and the evidence around antihypertensive treatment strategies.

Cardiometabolism 16.09.2026

Reducing Cardiovascular Mortality: New Insights from the Experts

Perindopril/Amlodipine in Hypertension: Expert Clinical Perspectives

Prof. Luis Alcocer and Prof. Stefano Masi share their clinical perspectives on hypertension management and the role of the perindopril/amlodipine combination in achieving effective BP control.

Cardiometabolism 16.09.2026

Perindopril/Amlodipine in Hypertension: Expert Clinical Perspectives

24-Hour BP Control: Why Blood Pressure Variability Matters

Prof. Anna Vachulová discusses the importance of 24-hour BP control and long-term BP variability, and how the perindopril/amlodipine combination contributes to sustained BP management.

Cardiometabolism 16.09.2026

24-Hour BP Control: Why Blood Pressure Variability Matters

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

Cardiometabolism 16.09.2026

Perindopril: Cardiovascular Protection Across the Hypertension Continuum

ACE Inhibitors and Cough: What Is the Real Burden?

ACE Inhibitors and Cough: What Is the Real Burden?

Cardiometabolism 16.09.2026

ACE Inhibitors and Cough: What Is the Real Burden?

1
2
3
...
9

Next